Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB493494-2,61
PKN45,545,54-0,51
Msft-3,29
Nokia3,34053,4191,34
IBM-1,39
Daimler AG44,2844,291,28
PFE-0,69
24.09.2020 1:38:59
Indexy online
AD Index online
select
AD Index online
 

  • 23.09.2020 22:00:00
Anika Therapeut (ANIK.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
32,56 -2,43 -0,81 92 710
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.09.2020
Popis společnosti

Business Summary: Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
Financial Summary: BRIEF: For the six months ended 30 June 2020, Anika Therapeutics Inc revenues increased 20% to $66.1M. Net loss totaled $1.9M vs. income of $13.9M. Revenues reflect Other segment increase of 34% to $3.8M, United States segment increase of 20% to $51.4M, Other. segment increase from $2.6M to $6.5M. Net loss reflects Selling, general & administrative - Bala increase from $12.8M to $27.7M (expense).



  • Poslední aktualizace: 24.09.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardGregory Maffei5810.04.201310.04.2013
PresidentScott Greenstein5926.12.2018
Chief Executive Officer, DirectorJames Meyer6426.12.201806.05.2004
Senior Executive Vice President and Chief Financial OfficerDavid Frear6203.07.201516.06.2003
President, Sales, Marketing and OperationsJennifer Witz5005.03.2019
Executive Vice President, Chief Administrative OfficerDara Altman6026.09.200826.09.2008
Executive Vice President, Secretary and General CounselPatrick Donnelly57
Executive Vice President - Sales and AutomotiveStephen Cook63
Executive Vice President, Chief Innovation OfficerJames Cady5806.03.201917.07.2015
Executive Vice President and Division President, Connected VehicleJoseph Verbrugge4905.03.2019